Kaminoyama, Japan

Kenji Abiko


Average Co-Inventor Count = 4.5

ph-index = 2

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 1989-1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kenji Abiko: Innovator in Biochemical Patents

Introduction

Kenji Abiko is a notable inventor based in Kaminoyama, Japan. He has made significant contributions to the field of biochemistry, particularly through his innovative patents. With a total of 3 patents, Abiko has focused on developing compounds that have practical applications in various industries.

Latest Patents

One of his latest patents is for Sodium N-acetylneuraminate trihydrate. This compound is represented by a specific formula and can be prepared by dissolving sodium N-acetylneuraminate in water or a mixture of water and an organic solvent. The process involves allowing the solution to stand, precipitating and separating the resulting crystals, and then drying them. This compound exhibits very low hygroscopicity, making it easy to handle in powder form. Another significant patent is for a repairing agent for cells and tissues. This agent comprises a compound of a general formula where Z can represent various elements depending on the value of n. This innovation has potential applications in medical and therapeutic fields.

Career Highlights

Kenji Abiko is associated with Mect Corporation, where he continues to work on groundbreaking research and development. His expertise in biochemistry has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

Abiko has collaborated with notable colleagues such as Shikoh Minagawa and Hiroshi Shinohara. Their combined efforts have contributed to advancing research in their respective fields.

Conclusion

Kenji Abiko's work exemplifies the spirit of innovation in biochemistry. His patents not only showcase his inventive capabilities but also hold promise for future applications in various industries.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…